Status:
RECRUITING
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Lead Sponsor:
Vanderbilt-Ingram Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
RATIONALE: Collecting and storing samples of tissue, blood, and urine from patients with or without breast cancer to study in the laboratory may help the study of cancer. PURPOSE: This research study...
Detailed Description
OBJECTIVES: * To create a database that includes environmental, demographic, phenotypic, clinical, pathologic, genetic, and prognostic factors in large cohorts of women with different stages of breas...
Eligibility Criteria
Inclusion
- Breast lesion which is suspected to be cancer or a known diagnosis of breast cancer (any stage, at any point in the disease trajectory) who agrees to donate tissue/body fluids.
- Individuals of all races and ethnic groups are eligible for this trial. There is no restriction regarding age, race, or ethnicity. The trial is open to the accrual of men and women.
- Must sign informed consent for study of tumor specimens as part of a research project.
- Must give permission for their tumor specimens to be obtained from outside institutions for molecular analyses.
- Must be willing to be followed for recurrence, relapse and death from disease.
- ELIGIBILITY CRITERIA FOR OPTIONAL PHYSICAL FUNCTION AND COGNITIVE ASSESSMENTS
- Must be 60 years of age or older
- Have completed initial round of cancer treatment
- Have completed the optional online survey and opted-in for the physical function and cognitive assessments
Exclusion
Key Trial Info
Start Date :
January 22 2004
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT00899301
Start Date
January 22 2004
End Date
March 1 2027
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States, 37232-6838